DBVT · DBV Technologies ADR
United States · RS rating 20 · As of 2026-11-03
| Price | 10.11 USD |
|---|---|
| 1-day change | +11.7% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 48 / 22 / 31 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 7 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -9.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +58.8% |
| Market cap (USD) | $1.1B |